Breaking News

Vetter Gains Approval for New Production Plant

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vetter Pharma-Fertigung GmbH & Co. KG has received a manufacturing license in accordance with the German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant, Ravensburg Vetter South. After just three years of planning and construction, the $130 million facility is now ready to begin work. According to the company, it can offer products of the highest quality, thanks to its high level of automation and its ultra-modern Restricted Access Barrier System. In addit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters